| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/21/1994 | WO1994016088A1 Anti-nutritional protein |
| 07/21/1994 | WO1994016087A1 Plant virus-resistant transgenic plants and method for producing same |
| 07/21/1994 | WO1994016086A1 Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same |
| 07/21/1994 | WO1994016085A2 Hybrid proteins having cross-linking and tissue-binding activities |
| 07/21/1994 | WO1994016084A1 Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens |
| 07/21/1994 | WO1994016083A1 Cloning of enterokinase and method of use |
| 07/21/1994 | WO1994016082A1 X-prolyl-dipeptidyl-aminopeptidase from lactobacillus delbrückii ssp. lactis, nucleic acids coding for the same and its use in fermented foodstuff preparation processes |
| 07/21/1994 | WO1994016081A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/21/1994 | WO1994016080A1 An in vitro/in vivo method for identifying anti-neoplastic drugs |
| 07/21/1994 | WO1994016079A2 Novel bacillus thuringiensis toxins active against corn rootworm larvae |
| 07/21/1994 | WO1994016078A2 High lysine derivatives of alpha-hordothionin |
| 07/21/1994 | WO1994016077A1 Method for breeding disease resistance into plants |
| 07/21/1994 | WO1994016076A1 Antimicrobial-protein-producing endosymbiotic microorganisms |
| 07/21/1994 | WO1994016075A2 Process for producing m-csf 223 |
| 07/21/1994 | WO1994016074A2 High molecular weight b-cell growth factor: interleukin-14 |
| 07/21/1994 | WO1994016073A2 Methods and reagents for inhibiting furin endoprotease |
| 07/21/1994 | WO1994016072A1 Vectors useful for controlling hiv-1 replication and methods for using the same |
| 07/21/1994 | WO1994016071A2 Assays and genes for cell death |
| 07/21/1994 | WO1994016070A1 Leukocyte derived growth factors |
| 07/21/1994 | WO1994016069A2 Ras associated gap proteins |
| 07/21/1994 | WO1994016068A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | WO1994016067A1 Serotoninergic receptors (5ht6 and 5ht7) and use thereof |
| 07/21/1994 | WO1994016066A1 Agents for the prevention and treatment of hiv replication and aids in humans |
| 07/21/1994 | WO1994016065A1 Producing cells for transplantation to reduce host rejection and resulting cells |
| 07/21/1994 | WO1994016063A1 Periplasmic 3':5'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same |
| 07/21/1994 | WO1994016062A1 Complement regulatory proteins of herpesvirus saimiri |
| 07/21/1994 | WO1994016059A1 Method for production of neuroblasts |
| 07/21/1994 | WO1994016057A1 Enhancer sequence for modulating expression in epithelial cells |
| 07/21/1994 | WO1994015969A1 Recombinant anti-hiv antibody and preparation thereof |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015964A1 NF-ATp, A T LYMPHOCYTE DNA-BINDING PROTEIN |
| 07/21/1994 | WO1994015963A1 Novel cell cortex protein |
| 07/21/1994 | WO1994015961A2 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | WO1994015953A1 Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015945A1 Antisense molecules directed against a fibroflast growth factor receptor gene family |
| 07/21/1994 | WO1994015943A1 Antisense molecules directed against a platelet derived growth factor receptor related gene |
| 07/21/1994 | WO1994015942A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
| 07/21/1994 | WO1994015646A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | WO1994015645A1 Antisense molecules directed against genes of the raf oncogene family |
| 07/21/1994 | WO1994015644A1 Compounds for targeting |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | WO1994015621A1 Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
| 07/21/1994 | WO1994015618A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | WO1994015616A1 Triplex forming oligonucleotides containing polymeric linkers |
| 07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
| 07/21/1994 | WO1994015581A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | WO1994012670A3 Process for typing of hcv isolates |
| 07/21/1994 | WO1994012648A3 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 07/21/1994 | WO1994012647A3 Novel serine protease from lymphocyte granules and use thereof |
| 07/21/1994 | WO1994012645A3 Cdna clone for human inducible nitric oxyde synthase and process for preparing same |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | WO1994012537A3 Granulocyte chemotactic protein |
| 07/21/1994 | DE4400659A1 Prodn. of viral membrane protein domains |
| 07/21/1994 | CA2153967A1 Nf-atp, a t lymphocyte dna-binding protein |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153504A1 Detection of synthetic oligonucleotides extracted from body fluids or tissues |
| 07/21/1994 | CA2153486A1 Ras associated gap proteins |
| 07/21/1994 | CA2153409A1 Leukocyte derived growth factors |
| 07/21/1994 | CA2153387A1 Dna sequencing by mass spectrometry |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153158A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/21/1994 | CA2153065A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
| 07/21/1994 | CA2153051A1 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | CA2153046A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | CA2152934A1 Viral amplification of recombinant messenger rna in transgenic plants |
| 07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | CA2152903A1 Antisense molecules directed against a fibroblast growth factor receptor gene family |
| 07/21/1994 | CA2152818A1 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | CA2152597A1 Method for production of neuroblasts |
| 07/21/1994 | CA2152509A1 Method to predict active growth of bacteria adhered to a surface |
| 07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
| 07/21/1994 | CA2152379A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | CA2152173A1 Method for breeding disease resistance into plants |
| 07/21/1994 | CA2113866A1 Antibodies for mevalonic acid and methods for determination of mevalonic acid |
| 07/20/1994 | EP0607080A1 New pro sequence for secretion of heterologous proteins from yeast cells |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0607005A2 Isolated DNA encoding the Not I restriction endonuclease and related methods for producing the same |
| 07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
| 07/20/1994 | EP0606917A2 A methylotropic and glucotropic mutant strain for producing a heterologous protein |
| 07/20/1994 | EP0606869A1 Promotor sequence of the p55 tumor necrosis factor receptor |
| 07/20/1994 | EP0606734A1 Human CNS receptors of the NMDA-R1 family |
| 07/20/1994 | EP0606518A1 Intercellular adhesion molecules and their binding ligands |
| 07/20/1994 | EP0606516A1 Anti-human ceruloplasmin monoclonal antibody |
| 07/20/1994 | EP0606464A1 Peptides capable of controlling acrosome reaction |
| 07/20/1994 | EP0606454A1 Dna constructs, cells and plants derived therefrom |
| 07/20/1994 | EP0606452A1 Vector vaccines of recombinant feline herpesvirus |
| 07/20/1994 | EP0606437A1 Non-shedding live herpesvirus vaccine |
| 07/20/1994 | EP0606430A1 Chimeric anti-cea antibody |
| 07/20/1994 | EP0606376A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 07/20/1994 | EP0606323A1 Dna, dna constructs, cells and plants derived therefrom |
| 07/20/1994 | EP0606280A1 New conjugates for the introduction of nucleic acid into higher eukaryotic cells |